MAIA

MAIA Biotechnology, Inc. AMEX Listed Jul 28, 2022

Healthcare ·Biotechnology ·US · MAIABiotech.com

$1.31

Mkt Cap $50.8M

52w Low $0.87 19.2% of range 52w High $3.19

50d MA $1.46 200d MA $1.54

P/E (TTM) -1.9x

EV/EBITDA 354.7x

P/B 18.1x

Debt/Equity 0.0x

ROE -942.7%

P/FCF -0.0x

RSI (14) —

ATR (14) —

Beta 0.32

50d MA $1.46

200d MA $1.54

Avg Volume 930.6K

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.

SIC Code

2834

CIK (SEC)

1878313

Phone

312 416 8592

444 West Lake Street · Chicago, IL 60606 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 23, 2026	AMC	-0.13	-0.08	+38.5%	1.49	+0.0%	-3.4%	+2.1%	-6.1%	-5.1%	+0.0%	—
Nov 7, 2025	AMC	-0.19	-0.27	-42.1%	1.12	+0.9%	+2.7%	-2.6%	-4.5%	-5.6%	+3.0%	—
Aug 11, 2025	AMC	-0.24	-0.18	+25.0%	1.49	+1.3%	+5.4%	+1.9%	-2.5%	+1.3%	+0.0%	—
May 9, 2025	AMC	-0.18	-0.16	+11.1%	2.04	-1.0%	-5.9%	-5.2%	-3.3%	+0.6%	+1.7%	—
Mar 21, 2025	AMC	-0.20	-0.17	+15.0%	1.76	-3.4%	-5.1%	-6.0%	+5.1%	-1.2%	-0.6%	—
Nov 12, 2024	AMC	-0.32	-0.11	+65.6%	2.62	-0.8%	-8.8%	-10.9%	+6.1%	+4.0%	-6.8%	—
Aug 9, 2024	AMC	-0.33	-0.17	+48.5%	2.66	-4.5%	+1.5%	+1.5%	+1.1%	+2.9%	+3.9%	—
May 14, 2024	AMC	-0.33	-0.46	-39.4%	2.84	+1.1%	+1.1%	+8.7%	+6.1%	+3.0%	+6.2%	—
Mar 21, 2024	AMC	-0.35	-0.41	-17.1%	1.94	+1.0%	+8.8%	+20.9%	-4.3%	+1.6%	-11.3%	—
Nov 7, 2023	AMC	-0.38	-0.36	+5.3%	2.25	-4.4%	-7.6%	-0.5%	-3.9%	-12.6%	+6.9%	—
Aug 8, 2023	AMC	-0.43	-0.35	+18.6%	2.10	+1.8%	+1.4%	-2.8%	+0.5%	-1.4%	-1.5%	—
May 8, 2023	AMC	-0.40	-0.38	+5.0%	2.65	+1.9%	+1.5%	+0.7%	-5.9%	-2.4%	+8.4%	—

Data updated apr 25, 2026 8:25pm · Source: massive.com